Skip to content
Trial Eligibility
Menu

The Metabolic Effects of Intermittent Fasting

NCT05722873

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Caloric restriction has beneficial metabolic effects in humans including weight loss and improvement in blood pressure and lipid levels. Intermittent fasting has emerged as a popular alternative to caloric restriction as it does not require daily adherence to a dietary protocol, but whether the benefits of fasting protocols are dependent on weight loss is not known. In this study, the investigators will explore the metabolic effects of fasting and evaluate whether these effects, including negative effects on bone metabolism, are independent of weight loss.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Normal and Overweight Individuals at High-risk of Diabetes

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
21 to 45 years
Sex
All
Healthy volunteers
Accepted
Sponsor
University of Pittsburgh
Last updated on ClinicalTrials.gov
May 18, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Pennsylvania · 1

  • University of Pittsburgh · Pittsburgh, PA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.